nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—SLC22A3—Vincristine—muscle cancer	0.204	0.218	CbGbCtD
Prazosin—CYP1A1—Dacarbazine—muscle cancer	0.154	0.165	CbGbCtD
Prazosin—ABCG2—Dactinomycin—muscle cancer	0.145	0.155	CbGbCtD
Prazosin—ABCG2—Vincristine—muscle cancer	0.0891	0.0952	CbGbCtD
Prazosin—ABCG2—Etoposide—muscle cancer	0.0817	0.0872	CbGbCtD
Prazosin—ABCG2—Doxorubicin—muscle cancer	0.0557	0.0595	CbGbCtD
Prazosin—ABCG2—Methotrexate—muscle cancer	0.054	0.0576	CbGbCtD
Prazosin—ABCB1—Dactinomycin—muscle cancer	0.0522	0.0557	CbGbCtD
Prazosin—ABCB1—Vincristine—muscle cancer	0.0321	0.0343	CbGbCtD
Prazosin—ABCB1—Etoposide—muscle cancer	0.0295	0.0314	CbGbCtD
Prazosin—ABCB1—Doxorubicin—muscle cancer	0.0201	0.0214	CbGbCtD
Prazosin—ABCB1—Methotrexate—muscle cancer	0.0195	0.0208	CbGbCtD
Prazosin—KCNH6—renal system—muscle cancer	0.00243	0.0602	CbGeAlD
Prazosin—MT3—head—muscle cancer	0.00228	0.0565	CbGeAlD
Prazosin—KCNH7—head—muscle cancer	0.00228	0.0565	CbGeAlD
Prazosin—MT3—testis—muscle cancer	0.0022	0.0546	CbGeAlD
Prazosin—KCNH7—testis—muscle cancer	0.0022	0.0546	CbGeAlD
Prazosin—KCNH6—head—muscle cancer	0.00162	0.0403	CbGeAlD
Prazosin—SLC22A2—renal system—muscle cancer	0.00144	0.0356	CbGeAlD
Prazosin—ADRA1B—renal system—muscle cancer	0.00137	0.0341	CbGeAlD
Prazosin—SLC22A3—embryo—muscle cancer	0.00128	0.0317	CbGeAlD
Prazosin—SLC22A1—renal system—muscle cancer	0.00101	0.0251	CbGeAlD
Prazosin—SLC22A3—smooth muscle tissue—muscle cancer	0.00101	0.025	CbGeAlD
Prazosin—SLC22A3—renal system—muscle cancer	0.000969	0.024	CbGeAlD
Prazosin—ADRA1B—head—muscle cancer	0.00092	0.0228	CbGeAlD
Prazosin—ADRA1D—head—muscle cancer	0.000899	0.0223	CbGeAlD
Prazosin—Retinal disorder—Methotrexate—muscle cancer	0.000862	0.0376	CcSEcCtD
Prazosin—HTR1A—renal system—muscle cancer	0.000838	0.0208	CbGeAlD
Prazosin—ORM1—bone marrow—muscle cancer	0.000837	0.0208	CbGeAlD
Prazosin—ADRA1A—renal system—muscle cancer	0.000772	0.0191	CbGeAlD
Prazosin—KCNH2—renal system—muscle cancer	0.000746	0.0185	CbGeAlD
Prazosin—SLC22A1—vagina—muscle cancer	0.000735	0.0182	CbGeAlD
Prazosin—SLC22A3—vagina—muscle cancer	0.000702	0.0174	CbGeAlD
Prazosin—SLC22A1—head—muscle cancer	0.000679	0.0168	CbGeAlD
Prazosin—HTR1D—head—muscle cancer	0.000672	0.0167	CbGeAlD
Prazosin—KCNH2—cardiac atrium—muscle cancer	0.000668	0.0166	CbGeAlD
Prazosin—SLC22A3—head—muscle cancer	0.000648	0.0161	CbGeAlD
Prazosin—CYP1A1—renal system—muscle cancer	0.00063	0.0156	CbGeAlD
Prazosin—SLC22A3—testis—muscle cancer	0.000626	0.0155	CbGeAlD
Prazosin—CYP1A1—cardiac atrium—muscle cancer	0.000564	0.014	CbGeAlD
Prazosin—KCNH2—bone marrow—muscle cancer	0.000564	0.014	CbGeAlD
Prazosin—HTR1A—head—muscle cancer	0.00056	0.0139	CbGeAlD
Prazosin—KCNH2—vagina—muscle cancer	0.00054	0.0134	CbGeAlD
Prazosin—ADRA2A—cardiac atrium—muscle cancer	0.000526	0.013	CbGeAlD
Prazosin—ADRA1A—head—muscle cancer	0.000517	0.0128	CbGeAlD
Prazosin—ABCG2—bone marrow—muscle cancer	0.000502	0.0124	CbGeAlD
Prazosin—KCNH2—head—muscle cancer	0.000499	0.0124	CbGeAlD
Prazosin—KCNH2—testis—muscle cancer	0.000482	0.012	CbGeAlD
Prazosin—ABCG2—vagina—muscle cancer	0.00048	0.0119	CbGeAlD
Prazosin—ADRA2A—tendon—muscle cancer	0.000458	0.0114	CbGeAlD
Prazosin—CYP1A1—vagina—muscle cancer	0.000456	0.0113	CbGeAlD
Prazosin—ABCB1—embryo—muscle cancer	0.000432	0.0107	CbGeAlD
Prazosin—ABCG2—testis—muscle cancer	0.000429	0.0106	CbGeAlD
Prazosin—ADRA2A—vagina—muscle cancer	0.000425	0.0105	CbGeAlD
Prazosin—CYP1A1—head—muscle cancer	0.000421	0.0104	CbGeAlD
Prazosin—ADRA2A—head—muscle cancer	0.000393	0.00974	CbGeAlD
Prazosin—ADRA2A—testis—muscle cancer	0.000379	0.00941	CbGeAlD
Prazosin—Erectile dysfunction—Vincristine—muscle cancer	0.000367	0.016	CcSEcCtD
Prazosin—Flushing—Dactinomycin—muscle cancer	0.000331	0.0145	CcSEcCtD
Prazosin—ABCB1—renal system—muscle cancer	0.000327	0.00811	CbGeAlD
Prazosin—Hallucination—Vincristine—muscle cancer	0.000317	0.0138	CcSEcCtD
Prazosin—Vasculitis—Methotrexate—muscle cancer	0.000316	0.0138	CcSEcCtD
Prazosin—Alopecia—Dactinomycin—muscle cancer	0.000315	0.0138	CcSEcCtD
Prazosin—Sweating increased—Etoposide—muscle cancer	0.000314	0.0137	CcSEcCtD
Prazosin—Ill-defined disorder—Dactinomycin—muscle cancer	0.000288	0.0126	CcSEcCtD
Prazosin—Alopecia—Vincristine—muscle cancer	0.000282	0.0123	CcSEcCtD
Prazosin—Malaise—Dactinomycin—muscle cancer	0.00028	0.0122	CcSEcCtD
Prazosin—Gynaecomastia—Methotrexate—muscle cancer	0.000276	0.012	CcSEcCtD
Prazosin—Discomfort—Dactinomycin—muscle cancer	0.000261	0.0114	CcSEcCtD
Prazosin—Oedema—Dactinomycin—muscle cancer	0.000253	0.0111	CcSEcCtD
Prazosin—Vertigo—Vincristine—muscle cancer	0.000249	0.0109	CcSEcCtD
Prazosin—ABCB1—bone marrow—muscle cancer	0.000247	0.00613	CbGeAlD
Prazosin—Flushing—Etoposide—muscle cancer	0.00024	0.0105	CcSEcCtD
Prazosin—ABCB1—vagina—muscle cancer	0.000237	0.00587	CbGeAlD
Prazosin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000231	0.0101	CcSEcCtD
Prazosin—Alopecia—Etoposide—muscle cancer	0.000228	0.00996	CcSEcCtD
Prazosin—Oedema—Vincristine—muscle cancer	0.000226	0.00988	CcSEcCtD
Prazosin—Hyperhidrosis—Vincristine—muscle cancer	0.000219	0.00955	CcSEcCtD
Prazosin—ABCB1—head—muscle cancer	0.000219	0.00543	CbGeAlD
Prazosin—Fatigue—Dactinomycin—muscle cancer	0.000219	0.00954	CcSEcCtD
Prazosin—Pain—Dactinomycin—muscle cancer	0.000217	0.00946	CcSEcCtD
Prazosin—Eye pain—Doxorubicin—muscle cancer	0.000214	0.00936	CcSEcCtD
Prazosin—ABCB1—testis—muscle cancer	0.000211	0.00524	CbGeAlD
Prazosin—Feeling abnormal—Dactinomycin—muscle cancer	0.000209	0.00912	CcSEcCtD
Prazosin—Ill-defined disorder—Etoposide—muscle cancer	0.000209	0.0091	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000206	0.009	CcSEcCtD
Prazosin—Insomnia—Vincristine—muscle cancer	0.000205	0.00894	CcSEcCtD
Prazosin—Paraesthesia—Vincristine—muscle cancer	0.000203	0.00888	CcSEcCtD
Prazosin—Malaise—Etoposide—muscle cancer	0.000203	0.00885	CcSEcCtD
Prazosin—Vertigo—Etoposide—muscle cancer	0.000202	0.00881	CcSEcCtD
Prazosin—Body temperature increased—Dactinomycin—muscle cancer	0.0002	0.00875	CcSEcCtD
Prazosin—Loss of consciousness—Etoposide—muscle cancer	0.000198	0.00862	CcSEcCtD
Prazosin—Fatigue—Vincristine—muscle cancer	0.000195	0.00852	CcSEcCtD
Prazosin—Pain—Vincristine—muscle cancer	0.000194	0.00845	CcSEcCtD
Prazosin—Constipation—Vincristine—muscle cancer	0.000194	0.00845	CcSEcCtD
Prazosin—Pancreatitis—Methotrexate—muscle cancer	0.000189	0.00827	CcSEcCtD
Prazosin—Discomfort—Etoposide—muscle cancer	0.000189	0.00825	CcSEcCtD
Prazosin—Hypersensitivity—Dactinomycin—muscle cancer	0.000187	0.00815	CcSEcCtD
Prazosin—Abdominal discomfort—Methotrexate—muscle cancer	0.000185	0.00808	CcSEcCtD
Prazosin—Asthenia—Dactinomycin—muscle cancer	0.000182	0.00794	CcSEcCtD
Prazosin—Tachycardia—Etoposide—muscle cancer	0.000179	0.00781	CcSEcCtD
Prazosin—Body temperature increased—Vincristine—muscle cancer	0.000179	0.00781	CcSEcCtD
Prazosin—Erectile dysfunction—Methotrexate—muscle cancer	0.000178	0.00777	CcSEcCtD
Prazosin—Hyperhidrosis—Etoposide—muscle cancer	0.000177	0.00774	CcSEcCtD
Prazosin—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000177	0.00772	CcSEcCtD
Prazosin—Diarrhoea—Dactinomycin—muscle cancer	0.000173	0.00757	CcSEcCtD
Prazosin—Drowsiness—Methotrexate—muscle cancer	0.000172	0.00752	CcSEcCtD
Prazosin—Hypersensitivity—Vincristine—muscle cancer	0.000167	0.00728	CcSEcCtD
Prazosin—Paraesthesia—Etoposide—muscle cancer	0.000165	0.00719	CcSEcCtD
Prazosin—Pancreatitis—Doxorubicin—muscle cancer	0.000164	0.00716	CcSEcCtD
Prazosin—Dyspnoea—Etoposide—muscle cancer	0.000164	0.00714	CcSEcCtD
Prazosin—Somnolence—Etoposide—muscle cancer	0.000163	0.00712	CcSEcCtD
Prazosin—Angina pectoris—Doxorubicin—muscle cancer	0.000163	0.00711	CcSEcCtD
Prazosin—Epistaxis—Methotrexate—muscle cancer	0.000162	0.00709	CcSEcCtD
Prazosin—Asthenia—Vincristine—muscle cancer	0.000162	0.00709	CcSEcCtD
Prazosin—Vomiting—Dactinomycin—muscle cancer	0.000161	0.00703	CcSEcCtD
Prazosin—Rash—Dactinomycin—muscle cancer	0.00016	0.00698	CcSEcCtD
Prazosin—Fatigue—Etoposide—muscle cancer	0.000158	0.0069	CcSEcCtD
Prazosin—Constipation—Etoposide—muscle cancer	0.000157	0.00685	CcSEcCtD
Prazosin—Pain—Etoposide—muscle cancer	0.000157	0.00685	CcSEcCtD
Prazosin—Diarrhoea—Vincristine—muscle cancer	0.000155	0.00676	CcSEcCtD
Prazosin—Pollakiuria—Doxorubicin—muscle cancer	0.000155	0.00675	CcSEcCtD
Prazosin—Feeling abnormal—Etoposide—muscle cancer	0.000151	0.0066	CcSEcCtD
Prazosin—Nausea—Dactinomycin—muscle cancer	0.000151	0.00657	CcSEcCtD
Prazosin—Dizziness—Vincristine—muscle cancer	0.00015	0.00654	CcSEcCtD
Prazosin—Drowsiness—Doxorubicin—muscle cancer	0.000149	0.00651	CcSEcCtD
Prazosin—Urticaria—Etoposide—muscle cancer	0.000146	0.00636	CcSEcCtD
Prazosin—Body temperature increased—Etoposide—muscle cancer	0.000145	0.00633	CcSEcCtD
Prazosin—Tinnitus—Methotrexate—muscle cancer	0.000144	0.00629	CcSEcCtD
Prazosin—Vomiting—Vincristine—muscle cancer	0.000144	0.00628	CcSEcCtD
Prazosin—Rash—Vincristine—muscle cancer	0.000143	0.00623	CcSEcCtD
Prazosin—Dermatitis—Vincristine—muscle cancer	0.000143	0.00623	CcSEcCtD
Prazosin—Headache—Vincristine—muscle cancer	0.000142	0.00619	CcSEcCtD
Prazosin—Epistaxis—Doxorubicin—muscle cancer	0.000141	0.00614	CcSEcCtD
Prazosin—Alopecia—Methotrexate—muscle cancer	0.000137	0.00596	CcSEcCtD
Prazosin—Bradycardia—Doxorubicin—muscle cancer	0.000136	0.00595	CcSEcCtD
Prazosin—Hypersensitivity—Etoposide—muscle cancer	0.000135	0.0059	CcSEcCtD
Prazosin—Nausea—Vincristine—muscle cancer	0.000135	0.00587	CcSEcCtD
Prazosin—Asthenia—Etoposide—muscle cancer	0.000132	0.00574	CcSEcCtD
Prazosin—Pruritus—Etoposide—muscle cancer	0.00013	0.00566	CcSEcCtD
Prazosin—Vision blurred—Methotrexate—muscle cancer	0.000127	0.00554	CcSEcCtD
Prazosin—Diarrhoea—Etoposide—muscle cancer	0.000126	0.00548	CcSEcCtD
Prazosin—Ill-defined disorder—Methotrexate—muscle cancer	0.000125	0.00545	CcSEcCtD
Prazosin—Tinnitus—Doxorubicin—muscle cancer	0.000125	0.00545	CcSEcCtD
Prazosin—Flushing—Doxorubicin—muscle cancer	0.000124	0.00542	CcSEcCtD
Prazosin—Malaise—Methotrexate—muscle cancer	0.000121	0.0053	CcSEcCtD
Prazosin—Dizziness—Etoposide—muscle cancer	0.000121	0.00529	CcSEcCtD
Prazosin—Vertigo—Methotrexate—muscle cancer	0.000121	0.00528	CcSEcCtD
Prazosin—Alopecia—Doxorubicin—muscle cancer	0.000118	0.00517	CcSEcCtD
Prazosin—Vomiting—Etoposide—muscle cancer	0.000117	0.00509	CcSEcCtD
Prazosin—Rash—Etoposide—muscle cancer	0.000116	0.00505	CcSEcCtD
Prazosin—Dermatitis—Etoposide—muscle cancer	0.000116	0.00504	CcSEcCtD
Prazosin—Headache—Etoposide—muscle cancer	0.000115	0.00502	CcSEcCtD
Prazosin—Arthralgia—Methotrexate—muscle cancer	0.000115	0.005	CcSEcCtD
Prazosin—Tension—Doxorubicin—muscle cancer	0.000114	0.00499	CcSEcCtD
Prazosin—Discomfort—Methotrexate—muscle cancer	0.000113	0.00494	CcSEcCtD
Prazosin—Nervousness—Doxorubicin—muscle cancer	0.000113	0.00494	CcSEcCtD
Prazosin—Vision blurred—Doxorubicin—muscle cancer	0.00011	0.0048	CcSEcCtD
Prazosin—Nausea—Etoposide—muscle cancer	0.000109	0.00476	CcSEcCtD
Prazosin—Ill-defined disorder—Doxorubicin—muscle cancer	0.000108	0.00472	CcSEcCtD
Prazosin—Hyperhidrosis—Methotrexate—muscle cancer	0.000106	0.00464	CcSEcCtD
Prazosin—Malaise—Doxorubicin—muscle cancer	0.000105	0.00459	CcSEcCtD
Prazosin—Vertigo—Doxorubicin—muscle cancer	0.000105	0.00457	CcSEcCtD
Prazosin—Syncope—Doxorubicin—muscle cancer	0.000105	0.00456	CcSEcCtD
Prazosin—Palpitations—Doxorubicin—muscle cancer	0.000103	0.0045	CcSEcCtD
Prazosin—Loss of consciousness—Doxorubicin—muscle cancer	0.000102	0.00447	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.0001	0.00437	CcSEcCtD
Prazosin—Insomnia—Methotrexate—muscle cancer	9.94e-05	0.00434	CcSEcCtD
Prazosin—Arthralgia—Doxorubicin—muscle cancer	9.92e-05	0.00433	CcSEcCtD
Prazosin—Paraesthesia—Methotrexate—muscle cancer	9.87e-05	0.00431	CcSEcCtD
Prazosin—Discomfort—Doxorubicin—muscle cancer	9.81e-05	0.00428	CcSEcCtD
Prazosin—Dyspnoea—Methotrexate—muscle cancer	9.8e-05	0.00428	CcSEcCtD
Prazosin—Somnolence—Methotrexate—muscle cancer	9.77e-05	0.00426	CcSEcCtD
Prazosin—Dry mouth—Doxorubicin—muscle cancer	9.71e-05	0.00424	CcSEcCtD
Prazosin—Oedema—Doxorubicin—muscle cancer	9.51e-05	0.00415	CcSEcCtD
Prazosin—Fatigue—Methotrexate—muscle cancer	9.47e-05	0.00413	CcSEcCtD
Prazosin—Pain—Methotrexate—muscle cancer	9.4e-05	0.0041	CcSEcCtD
Prazosin—Shock—Doxorubicin—muscle cancer	9.36e-05	0.00409	CcSEcCtD
Prazosin—Tachycardia—Doxorubicin—muscle cancer	9.29e-05	0.00405	CcSEcCtD
Prazosin—Hyperhidrosis—Doxorubicin—muscle cancer	9.2e-05	0.00401	CcSEcCtD
Prazosin—Feeling abnormal—Methotrexate—muscle cancer	9.05e-05	0.00395	CcSEcCtD
Prazosin—Urticaria—Methotrexate—muscle cancer	8.73e-05	0.00381	CcSEcCtD
Prazosin—Body temperature increased—Methotrexate—muscle cancer	8.69e-05	0.00379	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	8.67e-05	0.00378	CcSEcCtD
Prazosin—Insomnia—Doxorubicin—muscle cancer	8.61e-05	0.00376	CcSEcCtD
Prazosin—Paraesthesia—Doxorubicin—muscle cancer	8.54e-05	0.00373	CcSEcCtD
Prazosin—Dyspnoea—Doxorubicin—muscle cancer	8.48e-05	0.0037	CcSEcCtD
Prazosin—Somnolence—Doxorubicin—muscle cancer	8.46e-05	0.00369	CcSEcCtD
Prazosin—Fatigue—Doxorubicin—muscle cancer	8.2e-05	0.00358	CcSEcCtD
Prazosin—Pain—Doxorubicin—muscle cancer	8.14e-05	0.00355	CcSEcCtD
Prazosin—Constipation—Doxorubicin—muscle cancer	8.14e-05	0.00355	CcSEcCtD
Prazosin—Hypersensitivity—Methotrexate—muscle cancer	8.1e-05	0.00353	CcSEcCtD
Prazosin—Asthenia—Methotrexate—muscle cancer	7.88e-05	0.00344	CcSEcCtD
Prazosin—Feeling abnormal—Doxorubicin—muscle cancer	7.84e-05	0.00342	CcSEcCtD
Prazosin—Pruritus—Methotrexate—muscle cancer	7.77e-05	0.00339	CcSEcCtD
Prazosin—Urticaria—Doxorubicin—muscle cancer	7.56e-05	0.0033	CcSEcCtD
Prazosin—Body temperature increased—Doxorubicin—muscle cancer	7.52e-05	0.00328	CcSEcCtD
Prazosin—Diarrhoea—Methotrexate—muscle cancer	7.52e-05	0.00328	CcSEcCtD
Prazosin—Dizziness—Methotrexate—muscle cancer	7.27e-05	0.00317	CcSEcCtD
Prazosin—Hypersensitivity—Doxorubicin—muscle cancer	7.01e-05	0.00306	CcSEcCtD
Prazosin—Vomiting—Methotrexate—muscle cancer	6.99e-05	0.00305	CcSEcCtD
Prazosin—Rash—Methotrexate—muscle cancer	6.93e-05	0.00302	CcSEcCtD
Prazosin—Dermatitis—Methotrexate—muscle cancer	6.92e-05	0.00302	CcSEcCtD
Prazosin—Headache—Methotrexate—muscle cancer	6.88e-05	0.003	CcSEcCtD
Prazosin—Asthenia—Doxorubicin—muscle cancer	6.83e-05	0.00298	CcSEcCtD
Prazosin—Pruritus—Doxorubicin—muscle cancer	6.73e-05	0.00294	CcSEcCtD
Prazosin—Nausea—Methotrexate—muscle cancer	6.53e-05	0.00285	CcSEcCtD
Prazosin—Diarrhoea—Doxorubicin—muscle cancer	6.51e-05	0.00284	CcSEcCtD
Prazosin—Dizziness—Doxorubicin—muscle cancer	6.29e-05	0.00275	CcSEcCtD
Prazosin—Vomiting—Doxorubicin—muscle cancer	6.05e-05	0.00264	CcSEcCtD
Prazosin—Rash—Doxorubicin—muscle cancer	6e-05	0.00262	CcSEcCtD
Prazosin—Dermatitis—Doxorubicin—muscle cancer	5.99e-05	0.00262	CcSEcCtD
Prazosin—Headache—Doxorubicin—muscle cancer	5.96e-05	0.0026	CcSEcCtD
Prazosin—Nausea—Doxorubicin—muscle cancer	5.65e-05	0.00247	CcSEcCtD
